I don't mind small decreases in the quarterly growth % as long as they're keeping the momentum going.
It's a bit extreme to think they'll keep growing at 40-60% per quarter
Keeping in perspective, for Q4 FY16, the annualised cash revenue run rate was $8.0M.
For Q4 FY17, we're looking at approx $32.0M - or a 400% increase
I think it may be unreasonable to expect them to hit a annualised run rate of $128M in 12 months time
EDIT - that said, I wouldn't mind if we hit $128M!
- Forums
- ASX - By Stock
- BIG
- 9 month share price target is +$2.00 share
9 month share price target is +$2.00 share, page-89
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online